Medios AG (OTCMKTS:MEDOF) Sees Large Decrease in Short Interest

Medios AG (OTCMKTS:MEDOF) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totaling 1,924 shares, a decline of 42.8% from the April 30th total of 3,361 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Medios Stock Performance

Shares of MEDOF stock opened at C$13.64 on Thursday. Medios has a 52-week low of C$13.64 and a 52-week high of C$13.64. The stock’s 50-day moving average price is C$13.64 and its 200 day moving average price is C$13.64.

Medios Company Profile

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products.